CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE

被引：0

作者：

Jukic, Lucija Virovic ^{[1
,2
,3
]}

Grgurevic, Ivica ^{[1
,3
,4
,5
]}

Mikolasevic, Ivana ^{[3
,6
,7
]}

Kanizaj, Tajana Filipec ^{[1
,3
,8
]}

Milic, Sandra ^{[3
,6
,7
]}

Mrzljak, Anna ^{[1
,3
,9
]}

Premuzic, Marina ^{[3
,9
]}

Hrstic, Irena ^{[3
,6
,10
]}

Stromar, Ivana Knezevic ^{[3
,9
]}

Ljubicic, Neven ^{[1
,2
,3
,11
]}

Ostojic, Rajko ^{[1
,3
,9
]}

Shapeski, Sanja Stojsavljevic ^{[2
,3
]}

Amerl-Sakic, Vjekoslava ^{[12
,13
]}

Markovic, Nina Basic ^{[2
,6
,14
,15
]}

Rada, Marko ^{[16
,17
]}

Soldo, Dragan ^{[1
,2
,18
,19
,20
]}

Sobocan, Nikola ^{[1
,3
,8
]}

Lalovac, Milos ^{[3
,8
]}

Puljiz, Zeljko ^{[3
,21
]}

Podrug, Kristian ^{[3
,22
]}

Ladic, Dinko ^{[3
,23
]}

机构：

[1] Univ Zagreb, Sch Med, Zagreb, Croatia

[2] Sestre Milosrdnice Univ Hosp Ctr, Zagreb, Croatia

[3] Croatian Soc Gastroenterol, Zagreb, Croatia

[4] Univ Zagreb, Fac Pharm & Biochem, Zagreb, Croatia

[5] Dubrava Univ Hosp, Zagreb, Croatia

[6] Univ Rijeka, Sch Med, Rijeka, Croatia

[7] Rijeka Univ Hosp Ctr, Rijeka, Croatia

[8] Merkur Univ Hosp, Zagreb, Croatia

[9] Zagreb Univ Hosp Ctr, Zagreb, Croatia

[10] Pula Gen Hosp, Pula, Croatia

[11] Univ Zagreb, Sch Dent Med, Zagreb, Croatia

[12] Vjekoslava AmerlSak Family Med, Zagreb, Croatia

[13] Coordinat Croatian Family Med Prevent Programs, Zagreb, Croatia

[14] Nina Basic Markov Family Med Practice, Rijeka, Croatia

[15] Soc Teachers Gen Family Med, Rijeka, Croatia

[16] Healthcare Ctr Split, Dalmatia Cty, Split, Croatia

[17] Croatian Family Med Soc, Split, Croatia

[18] Ctr Healthcare Ctr, Zagreb, Croatia

[19] Andrija Stampar Sch Publ Hlth, Zagreb, Croatia

[20] Croatian Med Assoc, Croatian Soc Family Phys, Zagreb, Croatia

[21] Univ Split, Sch Med, Split, Croatia

[22] Split Univ Hosp Ctr, Split, Croatia

[23] Osijek Univ Hosp Ctr, Osijek, Croatia

来源：

ACTA CLINICA CROATICA | 2021年 / 60卷

关键词：

Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Metabolic syndrome; Fibrosis; Cirrhosis; Screening; Noninvasive methods; Diagnostics; Treatment; Hepatocellular carcinoma; LIFE-STYLE MODIFICATION; HEPATOCELLULAR-CARCINOMA HCC; PLACEBO-CONTROLLED TRIAL; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; FIBROSIS STAGE; WEIGHT-LOSS; AMINOTRANSFERASE LEVELS; NONINVASIVE DIAGNOSIS; MAGNETIC-RESONANCE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

the existence of other causes of liver injury and determine the stage of fibrosis as the most important factor in disease prognosis. Patients with initial stages of fibrosis continue to be monitored at the primary healthcare level with the management of metabolic risk factors, dietary measures, and increased physical activity. Patients with advanced fibrosis should be referred to a gastroenterologist/ hepatologist for further treatment, monitoring, and detection and management of complications.

引用

页码：36 / 52

页数：17

共 50 条

[31] Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment
Schreuder, Tim C. M. A.
Verwer, Bart J.
van Nieuwkerk, Carin M. J.
Mulder, Chris J. J.
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (16) : 2474 - 2486
[32] Nonalcoholic fatty liver disease: Diagnosis and relation to metabolic syndrome and approach to treatment
Steven D. Lidofsky
Current Diabetes Reports, 2008, 8 : 25 - 30
[33] Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications
Ballestri, Stefano
Romagnoli, Dante
Nascimbeni, Fabio
Francica, Giampiero
Lonardo, Amedeo
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (05) : 603 - 627
[34] Current treatment for nonalcoholic fatty liver disease
Katsiki, Niki
Athyros, Vasilios G.
Karagiannis, Asterios
Mikhailidis, Dimitri P.
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (13) : 2141 - 2142
[35] The Future of Nonalcoholic Fatty Liver Disease Treatment
Mazhar, Khurram
MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (01) : 57 - +
[36] Treatment strategies in nonalcoholic fatty liver disease
Tilg, H
Kaser, A
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (03): : 148 - 155
[37] Treatment strategies in nonalcoholic fatty liver disease
Herbert Tilg
Arthur Kaser
Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 148 - 155
[38] Which treatment for nonalcoholic fatty liver disease?
Moscatiello, S.
Marzocchi, R.
Villanova, N.
Bugianesi, E.
Marchesini, G.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (08) : 767 - 775
[39] Prevention and treatment of nonalcoholic fatty liver disease
Targher, Giovanni
Bellis, Alessandro
Fornengo, Paolo
Ciaravella, Francesca
Pichiri, Isabella
Perin, Paolo Cavallo
Trimarco, Bruno
Marchesini, Giulio
DIGESTIVE AND LIVER DISEASE, 2010, 42 (05) : 331 - 340
[40] Treatment of diabetes in nonalcoholic fatty liver disease
Bodis, K.
Roden, M.
DIABETOLOGE, 2016, 12 (07): : 486 - 493

← 1 2 3 4 5 →